We are reiterating our Buy rating and $22.50 price target and slightly raising our projections after Betterware registered below consensus 2Q24 results, but reiterated their 2024 guidance. Further, while we view the 2Q miss as driven by product shortages and shipping issues which are, in the near-term, somewhat out of management's control, we believe there were more than enough key positives, from continued turn in orders and top line at Betterware Mexico, further double-digit gains at JAFRA Mexico, earlier than expected turn at JAFRA USA and the start of expansion into the United States, for us to remain positive on BWMX and, with a dividend yield of over 9% to reiterate or Buy rating and $22.50 price target.

26 Jul 2024
BWMX: 2Q Review: Managing Into the Positives; Reiterate Buy, $22.50 PT
Betterware de Mexico, S.A.P.I. de C.V. (BWMX:NYS), 0 | DD3 Acquisition Corp (DDMX:NYSE), 0 | Estee Lauder Companies (EL:NYSE), 0 | Estee Lauder Companies Inc. Class A (EL:NYS), 0 | L'Oreal (OR:EPA), 0 | L'Oreal S.A. (OR:PAR), 0 | Medifast (MED:NYSE), 0 | Medifast, Inc. (MED:NYS), 0 | Nu Skin Enterprises (NUS:NYSE), 0 | Nu Skin Enterprises, Inc. Class A (NUS:NYS), 0

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
BWMX: 2Q Review: Managing Into the Positives; Reiterate Buy, $22.50 PT
Betterware de Mexico, S.A.P.I. de C.V. (BWMX:NYS), 0 | DD3 Acquisition Corp (DDMX:NYSE), 0 | Estee Lauder Companies (EL:NYSE), 0 | Estee Lauder Companies Inc. Class A (EL:NYS), 0 | L'Oreal (OR:EPA), 0 | L'Oreal S.A. (OR:PAR), 0 | Medifast (MED:NYSE), 0 | Medifast, Inc. (MED:NYS), 0 | Nu Skin Enterprises (NUS:NYSE), 0 | Nu Skin Enterprises, Inc. Class A (NUS:NYS), 0
- Published:
26 Jul 2024 -
Author:
Eric Beder -
Pages:
8 -
We are reiterating our Buy rating and $22.50 price target and slightly raising our projections after Betterware registered below consensus 2Q24 results, but reiterated their 2024 guidance. Further, while we view the 2Q miss as driven by product shortages and shipping issues which are, in the near-term, somewhat out of management's control, we believe there were more than enough key positives, from continued turn in orders and top line at Betterware Mexico, further double-digit gains at JAFRA Mexico, earlier than expected turn at JAFRA USA and the start of expansion into the United States, for us to remain positive on BWMX and, with a dividend yield of over 9% to reiterate or Buy rating and $22.50 price target.